AKT1 and prostate carcinoma: EPA and DHA have been reported to inhibit growth and progression of prostate cancer, induce apoptosis via the PI3K/AKT pathway and reduce oxidative stress and inflammation via inhibition of the COX and lipooxygenase (LOX) pathways [25, 46–50].